From: Economic impact of homeopathic practice in general medicine in France
Type de medicines | CM group | Mx group | Ho group | p |
---|---|---|---|---|
(N = 1691) | (N = 3187) | (N = 1501) | ||
A: Diseases of the respiratory system including otolaryngology | ||||
At least one analgesic or NSAID (N02 and M01) | 590 (34.9) | 1013 (31.8) | 261 (17.4) | <0.0001 |
At least one nasal preparation (R01) | 158 (9.3) | 277 (8.7) | 50 (3.3) | <0.0001 |
At least one antibiotic (J01) | 186 (11.0) | 341 (10.7) | 90 (6.0) | <0.0001 |
B: Diseases of the musculoskeletal system | ||||
At least one analgesic (N02A and N02B) | 123 (7.3) | 200 (6.3) | 37 (2.5) | <0.0001 |
At least one NSAID (without ASA) (M01A) | 286 (16.9) | 479 (15.0) | 129 (8.6) | <0.0001 |
C: Neurotic disorders and sleep disorders | ||||
At least one psychotropic drug (N03, N05, N06) | 512 (10.4) | 778 (9.1) | 294 (5.7) | <0.0001 |
At least one anxiolytic (N05B) | 162 (9.6) | 245 (7.7) | 77 (5.1) | <0.0001 |
At least one hypnotic or sedative (N05C) | 81 (4.8) | 121 (3.8) | 42 (2.8) | 0.014 |
At least one antidepressant (N06A) | 166 (9.8) | 248 (7.8) | 74 (4.9) | <0.0001 |